Dlk Investment Management, LLC Black Diamond Therapeutics, Inc. Transaction History
Dlk Investment Management, LLC
- $261 Billion
- Q3 2024
A detailed history of Dlk Investment Management, LLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Dlk Investment Management, LLC holds 16,215 shares of BDTX stock, worth $53,347. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,215
Previous 16,215
-0.0%
Holding current value
$53,347
Previous $75.6 Million
6.65%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding BDTX
# of Institutions
101Shares Held
47.2MCall Options Held
108KPut Options Held
24.8K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$35.1 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.52MShares$28 Million0.66% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$14.6 Million1.96% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$10.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.13MShares$7.01 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $120M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...